Youngil Lafutidine Tablet

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine per dose, taken orally twice daily in the morning and at bedtime. In clinical trials of up to 8 weeks, most ulcers healed within 8 weeks, although healing time may vary in some patients. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine per dose, taken orally twice daily in the morning and at bedtime. In clinical trials of up to 6 weeks, most ulcers healed within 6 weeks, although healing time may vary in some patients. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10mg of lafutidine once daily, taken orally at bedtime. In clinical trials of up to 2 weeks, most lesions healed within 2 weeks, although healing time may vary in some patients. 4. Combination therapy with antibiotics for patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia: The usual dose is 10mg of lafutidine per dose, administered orally twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine per dose, twice daily.

This medication should not be used by patients who are allergic to any of its ingredients. Additionally, since this medication contains lactose, patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption should not take it. Patients with a history of hypersensitivity to the drug, liver or kidney function problems, those on dialysis, and the elderly should use this medication with special caution. This drug can cause severe allergic reactions such as anaphylaxis or shock, so if symptoms like pallor, decreased blood pressure, or difficulty breathing occur after taking it, administration should be stopped immediately and healthcare professionals should be notified. Liver dysfunction or jaundice symptoms may appear, so regular liver function tests should be conducted, and if abnormalities are found, the medication should be discontinued, and treatment should be sought. This medication may have blood-related side effects such as agranulocytosis or thrombocytopenia, so if symptoms such as sore throat, systemic fatigue, or fever occur, immediate consultation with a healthcare professional is necessary. Rare serious adverse reactions such as skin rashes, convulsions, and heart problems have been reported, so if any abnormal symptoms occur, a hospital visit is required. Mild side effects such as abdominal pain, diarrhea, constipation, headaches, insomnia, dizziness, malaise, heat sensation, facial flushing, increased white blood cell count, elevated eosinophils, decreased white blood cell count, decreased red blood cell count, decreased hematocrit, elevated LDH, elevated TTT, proteinuria, increased BUN, elevated serum uric acid, increased Cl, delayed menstruation, increased Na, decreased K, gynecomastia, edema, fatigue, abdominal pain, dyspepsia, enteritis, and gastric ulcers may occur, but most are transient. Symptoms of malignancy may be masked during the use of this medication, so if weight loss, recurrent vomiting, or hematemesis occur, tests must be conducted. Particularly in cases where stomach cancer is suspected, the use of this medication should be stopped if malignancy is confirmed after initial testing. It is important to carefully observe the patient’s condition during treatment and not use it longer than necessary. The elderly may have decreased physical function, so dosage and administration intervals should be adjusted and used cautiously. In dialysis patients, drug concentration in the blood may increase, so treatment should begin with low doses and gradually adjusted. Pregnant women should take this medication only if the benefits outweigh the risks according to a physician's judgment, and breastfeeding women are advised against taking it as it may be excreted in breast milk. Safety for pediatric use has not been sufficiently confirmed, so it should be administered with caution to children. This medication should be kept out of reach of children and stored in its original container for safety.

• Shock
• symptoms of anaphylaxis
• facial pallor
• hypotension
• generalized rash
• respiratory distress
• hepatic dysfunction
• jaundice
• agranulocytosis
• pharyngitis

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degrees and 30 degrees Celsius.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle